1. Home
  2. STTK vs XRN Comparison

STTK vs XRN Comparison

Compare STTK & XRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.10

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

XRN

Chiron Real Estate Inc. Common Stock

N/A

Current Price

$37.73

Market Cap

454.5M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
STTK
XRN
Founded
2016
2011
Country
United States
United States
Employees
N/A
30
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
538.3M
454.5M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
STTK
XRN
Price
$6.10
$37.73
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
522.7K
184.9K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
8.56%
EPS Growth
53.02
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
$4.50
Revenue Next Year
N/A
$3.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$29.05
52 Week High
$8.33
$37.81

Technical Indicators

Market Signals
Indicator
STTK
XRN
Relative Strength Index (RSI) 42.55 63.47
Support Level $5.85 $32.72
Resistance Level $6.81 N/A
Average True Range (ATR) 0.52 1.38
MACD -0.12 0.25
Stochastic Oscillator 23.03 95.78

Price Performance

Historical Comparison
STTK
XRN

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About XRN Chiron Real Estate Inc. Common Stock

Chiron Real Estate Inc is a real estate investment trust focused on investing and actively managing critical healthcare infrastructure. Its portfolio includes Spectrum-Dumfries, Slippery Rock MOB, Gainesville Eye Center, Aurora Sports Health, and many Others. Geographically, the company has it's concentration in a small number of states, including Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois.

Share on Social Networks: